FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916615202> ?p ?o ?g. }

• W2916615202 endingPage "215" @default.
• W2916615202 startingPage "208" @default.
• W2916615202 abstract "BackgroundInflammation is a cardiovascular risk factor in hemodialysis patients, but its influence on vascular access patency is still debatable. Our prospective study investigated this issue.MethodsA total of 258 patients receiving an arteriovenous fistula (AVF) between 2006 and 2016 at the Municipal Hospital Arad were included. Demographic, clinical, and laboratory characteristics were collected at the time of creation of the AVF. The primary study end point was AVF patency loss, defined as an event occurring at least 2 months after AVF formation and requiring surgical revision or replacement of the fistula. The patients were followed up for a median time of 26 months.ResultsIn our group, the mean age was 59.7 ± 13.2 years (median, 62 years), and 60.1% were male. During follow-up, 134 patients (51.9%) maintained AVF patency, whereas 124 (48.1%) lost AVF patency within a mean time of 23.3 ± 28.1 months (median, 10.5 months). We found that age (hazard ratio [HR], 1.015; P = .035) and C-reactive protein (CRP) level (HR, 1.17; P < .0001) were associated with a higher risk of loss of AVF patency. The protective factors for AVF patency were autosomal dominant polycystic kidney disease (HR, 0.336; P = .009), pre-emptive AVF (HR, 0.648; P = .031), and higher level of triglycerides (HR, 0.998; P = .035). In the multivariate adjusted Cox model, CRP level remained an independent predictor for loss of AVF patency (HR, 1.17; 95% confidence interval, 1.1-1.3; P < .0001).ConclusionsIn our study, CRP level was an independent predictor of AVF patency loss, whereas better AVF survival was independently associated with autosomal dominant polycystic kidney disease and pre-emptive AVF. As a simple noninvasive marker of chronic inflammation, CRP level may be a useful tool to predict AVF outcomes. Further research is needed to assess the protective effects of inflammation reduction on AVF survival." @default.
• W2916615202 created "2019-03-02" @default.
• W2916615202 creator A5007247301 @default.
• W2916615202 creator A5013775503 @default.
• W2916615202 creator A5021459882 @default.
• W2916615202 creator A5025623411 @default.
• W2916615202 creator A5027381091 @default.
• W2916615202 creator A5036343596 @default.
• W2916615202 creator A5037519397 @default.
• W2916615202 creator A5040007887 @default.
• W2916615202 creator A5055449943 @default.
• W2916615202 creator A5055881474 @default.
• W2916615202 creator A5080101962 @default.
• W2916615202 date "2019-07-01" @default.
• W2916615202 modified "2023-10-18" @default.
• W2916615202 title "C-reactive protein as a prognostic risk factor for loss of arteriovenous fistula patency in hemodialyzed patients" @default.
• W2916615202 cites W123352716 @default.
• W2916615202 cites W1852546658 @default.
• W2916615202 cites W1966291568 @default.
• W2916615202 cites W1970390626 @default.
• W2916615202 cites W1972340186 @default.
• W2916615202 cites W1974983466 @default.
• W2916615202 cites W1977101792 @default.
• W2916615202 cites W1979187236 @default.
• W2916615202 cites W2003521419 @default.
• W2916615202 cites W2008934239 @default.
• W2916615202 cites W2016077087 @default.
• W2916615202 cites W2031270068 @default.
• W2916615202 cites W2047916422 @default.
• W2916615202 cites W2050239558 @default.
• W2916615202 cites W2051901724 @default.
• W2916615202 cites W2057897080 @default.
• W2916615202 cites W2068629997 @default.
• W2916615202 cites W2068949553 @default.
• W2916615202 cites W2074979134 @default.
• W2916615202 cites W2086486978 @default.
• W2916615202 cites W2107841374 @default.
• W2916615202 cites W2108281918 @default.
• W2916615202 cites W2119347960 @default.
• W2916615202 cites W2149147910 @default.
• W2916615202 cites W2211459013 @default.
• W2916615202 cites W2254934747 @default.
• W2916615202 cites W2416339397 @default.
• W2916615202 cites W2416760726 @default.
• W2916615202 cites W2460568388 @default.
• W2916615202 cites W2544194962 @default.
• W2916615202 cites W2563015704 @default.
• W2916615202 cites W2589457918 @default.
• W2916615202 cites W2599076725 @default.
• W2916615202 cites W2608400238 @default.
• W2916615202 cites W2747918695 @default.
• W2916615202 cites W2767551131 @default.
• W2916615202 cites W2794798720 @default.
• W2916615202 cites W4248429808 @default.
• W2916615202 cites W592614665 @default.
• W2916615202 doi "https://doi.org/10.1016/j.jvs.2018.10.100" @default.
• W2916615202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30792061" @default.
• W2916615202 hasPublicationYear "2019" @default.
• W2916615202 type Work @default.
• W2916615202 sameAs 2916615202 @default.
• W2916615202 citedByCount "13" @default.
• W2916615202 countsByYear W29166152022020 @default.
• W2916615202 countsByYear W29166152022021 @default.
• W2916615202 countsByYear W29166152022022 @default.
• W2916615202 countsByYear W29166152022023 @default.
• W2916615202 crossrefType "journal-article" @default.
• W2916615202 hasAuthorship W2916615202A5007247301 @default.
• W2916615202 hasAuthorship W2916615202A5013775503 @default.
• W2916615202 hasAuthorship W2916615202A5021459882 @default.
• W2916615202 hasAuthorship W2916615202A5025623411 @default.
• W2916615202 hasAuthorship W2916615202A5027381091 @default.
• W2916615202 hasAuthorship W2916615202A5036343596 @default.
• W2916615202 hasAuthorship W2916615202A5037519397 @default.
• W2916615202 hasAuthorship W2916615202A5040007887 @default.
• W2916615202 hasAuthorship W2916615202A5055449943 @default.
• W2916615202 hasAuthorship W2916615202A5055881474 @default.
• W2916615202 hasAuthorship W2916615202A5080101962 @default.
• W2916615202 hasBestOaLocation W29166152021 @default.
• W2916615202 hasConcept C126322002 @default.
• W2916615202 hasConcept C141071460 @default.
• W2916615202 hasConcept C164705383 @default.
• W2916615202 hasConcept C188816634 @default.
• W2916615202 hasConcept C207103383 @default.
• W2916615202 hasConcept C2776341189 @default.
• W2916615202 hasConcept C2778063415 @default.
• W2916615202 hasConcept C2779063477 @default.
• W2916615202 hasConcept C44249647 @default.
• W2916615202 hasConcept C50382708 @default.
• W2916615202 hasConcept C50440223 @default.
• W2916615202 hasConcept C71924100 @default.
• W2916615202 hasConceptScore W2916615202C126322002 @default.
• W2916615202 hasConceptScore W2916615202C141071460 @default.
• W2916615202 hasConceptScore W2916615202C164705383 @default.
• W2916615202 hasConceptScore W2916615202C188816634 @default.
• W2916615202 hasConceptScore W2916615202C207103383 @default.
• W2916615202 hasConceptScore W2916615202C2776341189 @default.
• W2916615202 hasConceptScore W2916615202C2778063415 @default.
• W2916615202 hasConceptScore W2916615202C2779063477 @default.

• next